• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
COV

CLEO DIAGNOSTICS LTD - Charts / Financials

3.90% ! 37.0¢
Market Cap $30.19M  !
Healthcare Medical Care
Add to My Watchlist

Cleo Diagnostics Limited is an ovarian cancer diagnostics company. Its principal... Cleo Diagnostics Limited is an ovarian cancer diagnostics company. Its principal activities involve the development and patent of a blood test for the detection of ovarian cancer. It focuses on bringing to market a blood test for the early diagnosis of ovarian cancer based on the novel CXCL10 biomarker, which is produced early and at high levels by ovarian cancers but is absent in non-malignant disease. It is advancing the availability of its blood test, under a modular execution strategy, which is designed to address all ovarian cancer detection markets with specific tests, including surgical triage, recurrence, high risk, and early-stage screening. Triage Test is a pre-surgical test to determine ovarian or adnexal mass for which surgical referral is required who have not yet been referred to an oncologist.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Day
Open 39.5¢   Day High 39.5¢   Day Low 36.5¢
Daily Volume 72278
Bids   Sellers
Number Price Volume   Number Price Volume
2 36.5¢ 26912   2 39.5¢ 17085

Directors & Senior Management

Dr. Richard Allman Chief Executive Officer, Executive Director
Dr. Andrew N. Stephens Chief Scientific Officer, Executive Director
Prof. Thomas W. Jobling Non-Executive Independent Director, Lead Medical Advisor
Ms. Pauline M. Moffatt Company Secretary
Mr. Adrien Michele Wing Non-Executive Chairman of the Board
Ms. Lucinda J. Nolan Non-Executive Independent Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
37.0¢ 		Change
-0.015(3.90%) 		Mkt cap ! $30.19M
Open High Low Value Volume
39.5¢ 39.5¢ 36.5¢ $27.02K 72.27K

Buyers (Bids)

No. Vol. Price($)
2 26912 36.5¢
 

Sellers (Offers)

Price($) Vol. No.
39.5¢ 17085 2
View Market Depth
Last trade - 14.52pm 29/07/2025 (20 minute delay) ?

Top Stories

One of the biggest jumps today is the most obscure: Beonic Ltd up +65%

The HotCopper forums collectively missed one of the day’s top gainers, as far as the list of most popular companies according to users goes. Beonic Ltd (ASX:BEO), an aviation-facing tech stock, has inked a deal to provide LIDAR-based passenger foot traffic data to seven airports i...
Wildcat’s PFS elicits lacklustre response Wildcat has issued a PFS for its Tabba Tabba project, but the market hasn’t liked it @ shares were down -8.3% at lunchtime. Some HotCopper users were concerned Wildcat has relied on assumed lithium prices well above what other majors like Pilbara Minerals (ASX:PLS) are currently s...
HotCopper Trends: Vection's $7M, Liontown dips & Wildcat PFS Let’s check in on what’s trending on the HotCopper forums on Tuesday. The following companies are catching eyes in the intraday session: Vection Technologies (ASX:VR1) @ Vection has received a contract extension from an undisclosed EU-based client worth just ove...
ASX Market Close: Index treads water as Energy stocks lead The ASX200 was trading flat late in Tuesday afternoon’s session.Utilities and Energy were the best performing sectors intraday, both in the green heading into market close. Financials was the biggest loser intraday, followed by Staples and Telecommunication.In the GreenStar Entert...
Emyria Advances kicks off National Rollout with Avive Health Agreement Clinical-stage biotech and mental health innovator Emyria Limited (ASX:EMD) has fired up its national expansion strategy by signing a landmark agreement with Avive Health, a growing private hospital operator, to establish its first Empax clinic in Queensland.Under the agreement, Emyria will integ...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.